Question 1

Does Jennison Associates own MDGL stock?

Accepted Answer

No. Jennison Associates exited its MDGL (Madrigal Pharmaceuticals) position in Q2 2023. Its Q1 2023 13F listed 32,987 shares worth $8M.

Question 2

How many shares of MDGL does Jennison Associates own?

Accepted Answer

None since Q2 2023, when Jennison Associates exited the position. Its Q1 2023 13F listed 32,987 shares worth $8M.

Question 3

What is Jennison Associates' MDGL position worth?

Accepted Answer

Jennison Associates' MDGL position was worth $8M in its Q1 2023 13F, before the exit in Q2 2023.

Question 4

Is Jennison Associates buying or selling MDGL?

Accepted Answer

In Q2 2023, Jennison Associates exited its entire MDGL position.

Question 5

When did Jennison Associates first buy MDGL?

Accepted Answer

Jennison Associates already held MDGL in its Q4 2018 13F, the earliest on record, and listed it in 11 quarterly 13F filings.